Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India
· Delayed Price · Currency is INR 924.70
+4.15 (0.45%)
May 23, 2025, 3:29 PM IST
Tatva Chintan Pharma Chem Revenue
In the fiscal year ending March 31, 2025, Tatva Chintan Pharma Chem had annual revenue of 3.83B INR, down -2.74%. Tatva Chintan Pharma Chem had revenue of 1.08B in the quarter ending March 31, 2025, with 9.77% growth.
Revenue
3.83B
Revenue Growth
-2.74%
P/S Ratio
5.66
Revenue / Employee
5.55M
Employees
689
Market Cap
21.66B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UltraTech Cement | 759.55B |
| Asian Paints | 339.06B |
| Grasim Industries | 1,484.78B |
| Vedanta | 1,507.25B |
| Pidilite Industries | 131.40B |
| Solar Industries India | 75.40B |
| Shree Cement | 192.83B |
| Jindal Steel & Power | 497.65B |